扬农化工(600486) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 reached ¥5,267,778,294.74, representing a year-on-year increase of 42.08%[3] - Net profit attributable to shareholders was ¥904,316,580.24, marking a significant increase of 103.51% compared to the same period last year[3] - The net cash flow from operating activities amounted to ¥789,353,356.17, reflecting a growth of 69.47% year-on-year[3] - Total operating revenue for Q1 2022 reached ¥5,267,778,294.74, a 42.3% increase from ¥3,707,660,042.47 in Q1 2021[17] - Net profit for Q1 2022 was ¥904,504,399.84, representing a 102.5% increase compared to ¥445,260,196.33 in Q1 2021[18] - The company reported a total profit of ¥1,074,677,408.03 for Q1 2022, compared to ¥532,138,496.75 in Q1 2021, marking a 102.5% increase[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥15,071,094,008.53, an increase of 15.03% from the end of the previous year[3] - As of March 31, 2022, the company's total assets reached approximately RMB 15.07 billion, an increase from RMB 13.10 billion as of December 31, 2021, representing a growth of about 14.97%[15] - The total current liabilities rose to RMB 7.04 billion, compared to RMB 5.72 billion, marking an increase of about 22.98%[13] - The company's total equity attributable to shareholders reached RMB 7.85 billion, up from RMB 6.94 billion, which is an increase of approximately 13.06%[15] - The company’s total liabilities increased to RMB 7.22 billion from RMB 6.16 billion, representing a growth of approximately 17.19%[15] Cash Flow - The company's cash and cash equivalents amounted to RMB 2.87 billion, up from RMB 2.27 billion in the previous year, indicating a year-over-year increase of approximately 26.19%[11] - The cash inflow from financing activities was CNY 96,158,291.94, down from CNY 349,461,963.10 in the prior period[20] - The net cash flow from financing activities was CNY 33,946,929.63, a decrease from CNY 249,529,417.87 in the previous year[20] - The total cash and cash equivalents at the end of the period reached CNY 2,516,874,982.41, up from CNY 2,151,029,148.35 at the end of the previous period[20] - The company reported a cash increase of CNY 610,836,752.39 during the period, compared to CNY 391,759,189.56 in the previous year[20] Research and Development - The company's R&D expenses increased by 56.86% due to higher investment in research and development activities[6] - Research and development expenses rose to ¥122,876,987.97, a 57% increase from ¥78,335,595.73 in Q1 2021[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 12,326[7] - The top shareholder, Syngenta Group Co., Ltd., held 36.17% of the shares, totaling 112,084,812 shares[7] Inventory and Receivables - Accounts receivable rose by 84.81%, driven by increased sales volume during the peak season for pesticide sales[5] - Accounts receivable increased significantly to RMB 3.77 billion from RMB 2.04 billion, reflecting a growth of approximately 84.93%[11] - Inventory decreased to RMB 1.73 billion from RMB 1.87 billion, showing a decline of about 7.48%[11] Financial Ratios - The weighted average return on equity was 12.23%, up by 4.98% compared to the previous year[3] - Basic earnings per share for Q1 2022 were ¥2.918, compared to ¥1.434 in Q1 2021, reflecting a 103.4% increase[18] Other Financial Information - The company reported a significant increase in short-term borrowings, which rose to RMB 309.33 million from RMB 275.93 million, reflecting an increase of approximately 12.09%[13] - The company's non-current liabilities decreased to RMB 181.21 million from RMB 431.78 million, indicating a reduction of approximately 58.10%[15] - The company has maintained a stable level of intangible assets, with a slight decrease from RMB 489.25 million to RMB 484.68 million[13] - The company did not apply the new accounting standards for the current year[22]